EU tech fund invests in Israeli firm that develops diabetes solutions
The investment is intended to fund human trials of a biological pancreas that produces insulin independently in the body and renders further injections unnecessary.
The pancreas created by Israeli company Betalin Therapeutics.(photo credit: YOSSI ZAMIR)ByJERUSALEM POST STAFFUpdated:
